<DOC>
	<DOC>NCT02477111</DOC>
	<brief_summary>INSIGHT is a postmarket clinical follow-up study in the European Union. The purpose of the study is to continue to evaluate the safety and effectiveness/performance of Incraft in subjects with abdominal aortic aneurysms requiring endovascular repair in routine clinical practice. Approximately 150 subjects will be enrolled and followed through 5-years postprocedure. Up to 25 sites in Europe may participate.</brief_summary>
	<brief_title>European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms</brief_title>
	<detailed_description>INSIGHT is a postmarket clinical follow-up study in the European Union. The purpose of the study is to continue to evaluate the safety and effectiveness/performance of Incraft in subjects with abdominal aortic aneurysms requiring endovascular repair in routine clinical practice. Approximately 150 subjects will be enrolled and followed through 5-years postprocedure. Up to 25 sites in Europe may participate. Subjects will be enrolled and followed at 1 month and 6 month post-procedure and annually up to 5 years.</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
	<criteria>1. Male or Female age 18 years or older 2. Femoral access vessels should be adequate to fit the selected delivery system 3. Proximal neck length ≥ 10mm 4. Aortic neck diameters ≥ 17mm and ≤ 31mm 5. Aortic neck suitable for suprarenal fixation 6. Infrarenal and suprarenal neck angulation ≤ 60° 7. Iliac fixation length ≥ 15mm 8. Iliac diameters ≥ 7mm and ≤ 22mm 9. Minimum overall AAA treatment length (proximal landing location to distal landing location) ≥ 128mm 10. Morphology suitable for aneurysm repair 11. Provide written informed consent and as applicable written confidentiality authorization prior to initiation of study procedures 12. Subject is willing to comply with the specified followup evaluation schedule 1. Subject has one of the following: 1. Aneurysm sac rupture or leaking abdominal aortic aneurysm 2. Mycotic, dissecting, or inflammatory abdominal aortic aneurysm 2. Known allergy or intolerance to nickel titanium (nitinol), Polyethylene terephthalate (PET), or polytetrafluoroethylene (PTFE) 3. Known contraindication to undergoing angiography or anticoagulation 4. Existing AAA surgical graft and/or a AAA stentgraft system 5. Women of child bearing potential whom are pregnant, lactating, or planning to become pregnant during the course of the trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Endovascular repair</keyword>
</DOC>